Lok Sabha Question No. 3652 (UNSTARRED), answered on 2026-03-13
Subject: Pharmaceutical & Medical Devices Promotion and Development Scheme
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Shri Daggumalla Prasada Rao

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No. 3652 TO BE ANSWERED ON THE 13 TH  MARCH 2026

## Pharmaceutical & Medical Devices Promotion and Development Scheme

## 3652. Shri Daggumalla Prasada Rao:

## Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

(a) the total number of beneficiaries under the Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS) during the last five years, State/district-wise and year-wise including Andhra Pradesh;

(b) the total amount sanctioned and disbursed under PMPDS, State-wise and year-wise;

(c) the number of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance under PMPDS during the last three years, State-wise and year-wise;

(d) the details of mega events organized including India Pharma and India Medical Device meets, their  frequency,  locations,  participating  States,  total  expenditure  incurred  and  outcomes achieved; and

(e) the number of organizations that have received logo support from the Department for their events, State-wise and the criteria followed for granting such non-financial support?

## ANSWER

## THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS

## (SMT. ANUPRIYA PATEL)

(a) to (d):    Pharmaceutical and Medical Devices Promotion and Development Scheme (PMPDS) aims to facilitate growth and development of pharmaceutical sector through study/survey reports, awareness programs, creation of databases and promotion of industry.

Since FY2021-22, Department has conducted 25 studies and evaluations on topics of importance to the Department and has organized/supported 65 events/workshops/seminars/webinars  across  the  country  to  sensitize  the  pharmaceutical  and medical devices industry on various topics through academic  institutions,  government autonomous bodies, firms empanelled with Government of India, National/State level industry associations,  non-profit  companies/organization  in  pharmaceutical  &  medical  devices  sector, private companies of good repute and Government agencies.

Seminars/workshops  conducted  under  the  scheme  are  organised  at  various  locations across the country including Andhra  Pradesh and are open to participants from the pharmaceutical and medical sectors nationwide.

The  total  amount  sanctioned  and  disbursed  under  PMPDS  year-wise  is  given  at Annexure-I.  The  number  of  seminars,  conferences,  workshops,  conventions  and  exhibitions supported  with  financial  assistance  under  PMPDS  during  the  last  three  years  is  given  at Annexure-II.

The details of mega events organised under PMPDS including India Pharma and India Medical Device meets, locations, participation from different states, total expenditure incurred including Grant-in-Aid under the PMPDS and outcomes achieved are at Annexure-III.

(e): Department of Pharmaceuticals have supported 20 events with non-financial logo support under PMPDS  since  2021-22.  The  non-financial  logo  support  is provided to various organizations for Pharma and Medical Device events in compliance with the scheme guidelines.

Annexure referred to in reply to part (a) to (d) of the Lok Sabha Unstarred Question No. 3652  for  answer  on  13.3.2026,  raised  by  Shri  Daggumalla  Prasada  Rao,  regarding Pharmaceutical and Medical Devices Promotion and Development Scheme

Details of amount sanctioned and disbursed for preparing various study reports and organizing various seminars, conferences, conventions, workshop and exhibitions under PMPDS during last five years.

|   S. No. | Item                                                 |   2021-22 |   2022-23 |   2023-24 |   2024-25 |   2025-26 (as on 12.3.2026) |
|----------|------------------------------------------------------|-----------|-----------|-----------|-----------|-----------------------------|
|        1 | Amount sanctioned (₹ in lakh) for studies and events |       2   |      3    |      7    |      4    |                        4.83 |
|        2 | Amount Disbursed (₹ in lakh) for studies and events  |       1.2 |      0.81 |      2.77 |      2.02 |                        1.8  |

Annexure referred to in reply to part (a) to (d) of the Lok Sabha Unstarred Question No. 3652  for  answer  on  13.3.2026,  raised  by  Shri  Daggumalla  Prasada  Rao,  regarding Pharmaceutical and Medical Devices Promotion and Development Scheme

Details of number of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance under PMPDS during the last three years

|   S. No. | Item                                                                                                     |   2022-23 |   2023-24 |   2024-25 |
|----------|----------------------------------------------------------------------------------------------------------|-----------|-----------|-----------|
|        1 | No. of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance |         3 |        11 |        14 |

## Annexure III

Annexure referred to in reply to part (a) to (d) of the Lok Sabha Unstarred Question No. 3652  for  answer  on  13.3.2026,  raised  by  Shri  Daggumalla  Prasada  Rao,  regarding Pharmaceutical and Medical Devices Promotion and Development Scheme

Details  of  mega  events  organised  under  PMPDS  including  India  Pharma  and  India  Medical Device meets, their locations, participating states, total expenditure incurred including Grant-inAid under the PMPDS and outcomes achieved.

|   S. No | Name of Mega Event                                       | Date of event                                       | Location(s)                        | Participating States                                                                                                                                                                                                                         |   Total Expendit ure incurred (₹ in lakh) | Key Outcomes Achieved                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|---------|----------------------------------------------------------|-----------------------------------------------------|------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|       1 | India Pharma and India Medical Device 2021 (Hybrid Mode) | 25.2.20 21 to 26.2.20 21 and 1.3.202 1 to 2.3.202 1 | FICCI, Federation House, New Delhi | Maharashtra, Karnataka, Gujarat, Rajasthan, Delhi, Haryana, Madhya Pradesh, Orissa, Goa, Uttar Pradesh, Telangana, Chhattisgarh, Kerala, Himachal Pradesh, Uttarakhand, Punjab and Andhra Pradesh through Andhra Pradesh MedTech Zone (AMTZ) |                                     18.52 | The India Pharma &India Medical Devices 2021 Conference advanced dialogue between government and industry on policy priorities and sectoral reforms. Key outcomes included emphasis on strengthening domestic manufacturing, enhancing resilient supply chains, promoting innovation and R&D, improving healthcare access, and supporting digital health and advanced medical technologies to position India as a global hub for affordable medicines and medical device manufacturing. |

|   S. No | Name of Mega Event                         | Date of event            | Location(s)                                  | Participating States                                                                                                                                                                                                                         |   Total Expendit ure incurred (₹ in lakh) | Key Outcomes Achieved                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|---------|--------------------------------------------|--------------------------|----------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|       2 | India Pharma and India Medical Device 2022 | 25.4.20 22 to 27.4.20 22 | Dr. Ambedkar International Centre, New Delhi | Maharashtra, Karnataka, Gujarat, Rajasthan, Delhi, Haryana, Madhya Pradesh, Orissa, Goa, Uttar Pradesh, Telangana, Chhattisgarh, Kerala, Himachal Pradesh, Uttarakhand, Punjab and Andhra Pradesh through Andhra Pradesh MedTech Zone (AMTZ) |                                     85.8  | The India Pharma 2022 and India Medical Device 2022 Conferences led to key outcomes including strengthened dialogue between government and industry on policy support and ease of doing business, promotion of domestic manufacturing and resilient supply chains, and greater focus on innovation, digital health, and advanced medical technologies. The deliberations also emphasized regulatory collaboration, value- based healthcare, and enhanced investments through industrial clusters and medical device parks to position India as a global hub for pharmaceuticals and |
|       3 | India Pharma and India Medical Device 2023 | 26.5.20 23 to 27.5.20 23 | Hotel Ashok, New Delhi                       | Maharashtra, Karnataka, Gujarat, Rajasthan, Delhi, Haryana, Madhya Pradesh, Orissa, Goa, Uttar Pradesh, Telangana, Chhattisgarh, Kerala, Himachal Pradesh, Uttarakhand, Punjab and Andhra Pradesh through Andhra Pradesh MedTech Zone (AMTZ) |                                    113.73 | The 8th Edition of India Pharma & India Medical Devices 2023 strengthened collaboration among government, regulators, industry, and academia to advance domestic manufacturing, innovation, and global competitiveness. Key outcomes included emphasis on scaling MedTech innovations to large-scale manufacturing,                                                                                                                                                                                                                                                                 |

| S. No   | Name of Mega Event       | Date of event            | Location(s)           | Participating States   | Total Expendit ure incurred (₹ in lakh)   | Key Outcomes Achieved                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|--------------------------|--------------------------|-----------------------|------------------------|-------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|         |                          |                          |                       |                        |                                           | strengthening quality and R&D capabilities, promoting digital transformation and biosimilars in pharmaceuticals, and fostering industry - academia partnerships to support sustainable growth of India's healthcare ecosystem.                                                                                                                                                                                                                                                                                                                                                                                  |
| 4.      | India Medtec h Expo 2023 | 17.8.20 23 to 19.8.20 23 | Gandhinagar , Gujarat |                        | 815.10                                    | The India MedTech Expo 2023 showcased India's growing capabilities in the medical devices sector and strengthened engagement among policymakers, industry, start-ups, academia, and international stakeholders. Key outcomes included promotion of indigenous innovations and start-ups, facilitation of global business partnerships through buyer - seller meetings, identification of investment opportunities, and enhanced collaboration in R&D, skill development, and advanced healthcare technologies, reinforcing India's position as an emerging hub for medical device manufacturing and innovation. |

*****